| 4588- | AgNPs, | Chit, | Solid-state tailored silver nanocomposites from chitosan: Synthesis, antimicrobial evaluation and molecular docking |
| - | in-vitro, | NA, | NA |
| 4587- | AgNPs, | Chit, | Multifunctional Silver Nanoparticles Based on Chitosan: Antibacterial, Antibiofilm, Antifungal, Antioxidant, and Wound-Healing Activities |
| - | in-vitro, | NA, | NA |
| 4586- | AgNPs, | Tyndall-effect-enhanced supersensitive naked-eye determination of mercury (II) ions with silver nanoparticles |
| 4585- | AgNPs, | Tyndall-effect-based colorimetric assay with colloidal silver nanoparticles for quantitative point-of-care detection of creatinine using a laser pointer pen and a smartphone |
| 4584- | AgNPs, | Silver Nanoparticles Synthesized Using Carica papaya Leaf Extract (AgNPs-PLE) Causes Cell Cycle Arrest and Apoptosis in Human Prostate (DU145) Cancer Cells |
| - | in-vitro, | Pca, | DU145 |
| 4583- | AgNPs, | Metal-Based Nanoparticles for Cardiovascular Diseases |
| - | Review, | NA, | NA |
| 4582- | AgNPs, | Silver CASRN 7440-22-4 | DTXSID4024305 |
| 4581- | AgNPs, | Antimicrobial, anticoagulant and antiplatelet activities of green synthesized silver nanoparticles using Selaginella (Sanjeevini) plant extract |
| 4580- | AgNPs, | Biogenic Synthesis of Antibacterial, Hemocompatible, and Antiplatelets Lysozyme Functionalized Silver Nanoparticles through the One-Step Process for Therapeutic Applications |
| - | in-vitro, | NA, | NA |
| 4579- | AgNPs, | Response of platelets to silver nanoparticles designed with different surface functionalization |
| 4578- | AgNPs, | Green synthesized novel silver nanoparticles and their application as anticoagulant and thrombolytic agents: A perspective |
| - | Review, | NA, | NA |
| 4577- | AgNPs, | Characterization of Antiplatelet Properties of Silver Nanoparticles |
| - | vitro+vivo, | Stroke, | NA |
| 4576- | AgNPs, | Nanosilver, Next-Generation Antithrombotic Agent |
| - | Study, | NA, | NA |
| 4573- | AgNPs, | Bioactive silver nanoparticles derived from Carica papaya floral extract and its dual-functioning biomedical application |
| - | in-vitro, | Var, | MCF7 | - | NA, | NA, | HEK293 |
| 5147- | AgNPs, | Size dependent anti-invasiveness of silver nanoparticles in lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 5146- | AgNPs, | Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells Is Size-Dependent |
| - | in-vitro, | Liver, | HepG2 |
| 5145- | AgNPs, | Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | T47D |
| 5144- | AgNPs, | Differential effects of silver nanoparticles on DNA damage and DNA repair gene expression in Ogg1-deficient and wild type mice |
| - | in-vivo, | Nor, | NA |
| - | in-vitro, | CRC, | HCT116 |
| 5142- | AgNPs, | Biosynthesized Protein-Capped Silver Nanoparticles Induce ROS-Dependent Proapoptotic Signals and Prosurvival Autophagy in Cancer Cells |
| - | in-vitro, | CRC, | HUH7 |
| 888- | AgNPs, | Antibacterial Effects of Silver Nanoparticles on the Bacterial Strains Isolated from Catheterized Urinary Tract Infection Cases |
| - | in-vivo, | UTI, | NA |
| 887- | AgNPs, | Antibacterial potential of silver nanoparticles against isolated urinary tract infectious bacterial pathogens |
| - | in-vitro, | UTI, | NA |
| 328- | AgNPs, | Rad, | Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma |
| - | vitro+vivo, | GBM, | U251 |
| 343- | AgNPs, | Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma |
| - | in-vitro, | PC, | PANC1 |
| 342- | AgNPs, | Silver nanoparticles; a new hope in cancer therapy? |
| - | Review, | NA, | NA |
| 341- | AgNPs, | Bioprospecting a native silver-resistant Bacillus safensis strain for green synthesis and subsequent antibacterial and anticancer activities of silver nanoparticles |
| - | in-vitro, | Liver, | HepG2 |
| 340- | AgNPs, | Screening bioactivities of Caesalpinia pulcherrima L. swartz and cytotoxicity of extract synthesized silver nanoparticles on HCT116 cell line |
| - | in-vitro, | CRC, | HCT116 |
| 339- | AgNPs, | Cancer cell specific cytotoxic potential of the silver nanoparticles synthesized using the endophytic fungus, Penicillium citrinum CGJ-C2 |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Melanoma, | A431 | - | in-vitro, | HCC, | HepG2 |
| 338- | AgNPs, | Biogenic silver nanoparticles: In vitro and in vivo antitumor activity in bladder cancer |
| - | vitro+vivo, | Bladder, | 5637 |
| 337- | AgNPs, | immuno, | Silver nanoparticle induced immunogenic cell death can improve immunotherapy |
| - | Review, | NA, | NA |
| 336- | AgNPs, | PDT, | Photodynamic ability of silver nanoparticles in inducing cytotoxic effects in breast and lung cancer cell lines |
| - | in-vitro, | BC, | MCF7 |
| 335- | AgNPs, | PDT, | Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy |
| - | Review, | NA, | NA |
| 334- | AgNPs, | Silver-Based Nanoparticles Induce Apoptosis in Human Colon Cancer Cells Mediated Through P53 |
| - | in-vitro, | Colon, | HCT116 |
| 333- | AgNPs, | HPT, | Enhancement effect of cytotoxicity response of silver nanoparticles combined with thermotherapy on C6 rat glioma cells |
| - | in-vivo, | GBM, | NA |
| 332- | AgNPs, | Rad, | Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy |
| - | in-vivo, | GBM, | NA |
| 331- | AgNPs, | Rad, | Silver nanoparticles: a novel radiation sensitizer for glioma? |
| - | vitro+vivo, | GBM, | NA |
| 330- | AgNPs, | Rad, | Reactive oxygen species acts as executor in radiation enhancement and autophagy inducing by AgNPs |
| - | in-vitro, | GBM, | U251 |
| 329- | AgNPs, | Rad, | Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells |
| - | in-vitro, | GBM, | U251 |
| 375- | AgNPs, | ALA, | Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vivo, | NA, | NA |
| 327- | AgNPs, | MS-275, | Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells |
| - | in-vitro, | Lung, | A549 |
| 326- | AgNPs, | TSA, | Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles |
| - | in-vitro, | Cerv, | HeLa |
| 325- | AgNPs, | Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer |
| 324- | AgNPs, | CPT, | Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells |
| - | in-vitro, | Cerv, | HeLa |
| 322- | AgNPs, | Cisplatin, | Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | OVCAR-3 |
| 321- | AgNPs, | I-131 doping of silver nanoparticles platform for tumor theranosis guided drug delivery |
| - | in-vivo, | NA, | NA |
| 320- | AgNPs, | Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish |
| - | vitro+vivo, | NA, | HUH7 |
| 319- | AgNPs, | Endoplasmic reticulum stress signaling is involved in silver nanoparticles-induced apoptosis |
| 318- | AgNPs, | Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 317- | AgNPs, | Autophagic effects and mechanisms of silver nanoparticles in renal cells under low dose exposure |
| - | in-vitro, | Kidney, | HEK293 |
| 316- | AgNPs, | Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid